The Market Overreacted to the DEA's Marijuana Rescheduling -- Here's What It Means for Canopy Growth Stock Now

Medical marijuana was moved to the DEA's Schedule III from Schedule I. This confers some accounting advantages, at best, and the company can't even capitalize on them yet.
Open original source